Subcutaneous defibrillators for dialysis patients

Tushar J. Vachharajani, Loay Salman, Eric J. Costanzo, Sushil K. Mehandru, Mayurkumar Patel, Dawn M. Calderon, Roy O. Mathew, Mandeep S. Sidhu, Arif Asif

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement. Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.

Original languageEnglish (US)
Pages (from-to)4-8
Number of pages5
JournalHemodialysis International
Issue number1
StatePublished - Jan 2018


  • Subcutaneous defibrillator
  • dialysis catheter
  • hemodialysis

ASJC Scopus subject areas

  • Hematology
  • Nephrology


Dive into the research topics of 'Subcutaneous defibrillators for dialysis patients'. Together they form a unique fingerprint.

Cite this